Sub headings in a bold font and increased point size Placeholder introduction copy: IPF is a form of lung disease that causes scarring (fibrosis) of the lungs; people living with IPF have a poor prognosis and symptoms that significantly impact their quality of life.
Since 2013, the Registry has collected real-world clinical data on over 5,000 IPF patients from 64 centres across the UK. These findings provide valuable insights into patient demographics, diagnostic trends, and treatment patterns, shaping the future of IPF care.
Chair of the Committee
Chair of the Committee
Chair of the Committee
Chair of the Committee